Related Experiment Video

Updated: Jul 14, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

[The prognosis and risk factors of cardiovascular complications in patients with chronic glomerulonephritis]

S B Mukasheva, E A Movchan

    Klinicheskaia Meditsina
    |May 25, 2007
    PubMed

    Insights

    Chronic glomerulonephritis (CGN) patients face a high risk of fatal cardiovascular events. Key risk factors include male sex, age over 55, smoking, hypertension, and specific lipid profiles.

    Area of Science:

    • Nephrology
    • Cardiology
    • Public Health

    Context:

    • Chronic glomerulonephritis (CGN) is a significant kidney disease.
    • Cardiovascular disease (CVD) poses a major threat to CGN patients.
    • Assessing long-term prognosis in CGN is crucial for patient management.

    Purpose:

    • To evaluate the 10-year prognosis of cardiovascular diseases in CGN patients.
    • To identify key risk factors for fatal cardiovascular events in this population.
    • To correlate prognosis with established risk scales like SCORE.

    Summary:

    • A study of 90 individuals with chronic glomerulonephritis (CGN) revealed that 34.4% are at high risk for severe atherosclerotic complications, including myocardial infarction and stroke.
    • Leading risk factors identified were male sex, age >55 years, smoking, and severe arterial hypertension (both systolic and diastolic).
    • Specific lipid abnormalities, such as IIb phenotype hyperlipidemia and reduced high-density lipoprotein cholesterol, significantly increased the risk of cardiovascular events.

    Impact:

    • Highlights the substantial cardiovascular risk in CGN patients.
    • Informs clinical practice regarding risk stratification and preventative strategies for CGN patients.
    • Emphasizes the need for comprehensive management of risk factors in this vulnerable group.

    More Related Videos

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy07:52

    A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

    Published on: November 7, 2017

    Related Concept Videos

    Chronic Kidney Disease I: Introduction01:25

    Chronic Kidney Disease I: Introduction

    Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
    Chronic Kidney Disease II: Clinical Manifestations01:24

    Chronic Kidney Disease II: Clinical Manifestations

    Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
    Diabetic Nephropathy01:28

    Diabetic Nephropathy

    Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
    Acute Kidney Injury III: Clinical Manifestations01:29

    Acute Kidney Injury III: Clinical Manifestations

    Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...